Pembroke VCT, the venture capital trust focused on building the brands of tomorrow, has made an initial investment of £1 million into Credentially, the platform that automates healthcare hiring, onboarding and compliance. During the pandemic, the company has worked with the NHS to speed up the registration of healthcare professionals.

Credentially was launched in 2016 by founders Kit Latham, a former A&E doctor and Artem Stalpouski, a software engineer. They combined their experience and expertise to address the lengthy hiring processes, disjointed onboarding efforts and fragmented compliance reporting that healthcare providers currently experience.

BGF, the UK’s most active investor in growth economy businesses, has successfully exited its investment in Renal Services, an independent provider of dialysis services, after it was acquired by DaVita UK Limited, a DaVita International Group Company.

London-based Vamstar, which is creating the world's first AI powered B2B healthcare marketplace, has completed a $1.7 million seed funding led by btov with participation from Antler and Begin Capital.

The Imperial College Innovation Fund (ICIF), an early-stage investment fund launched at Imperial in early 2020 and managed by Parkwalk Advisors to invest in early-stage, high-growth, knowledge-intensive companies, has completed its first investment of £205,000 into Charco Neurotech. 

The team of designers, doctors, engineers and scientists at Charco Neurotech are developing a non-invasive vibrating device called CUE1 to help manage Parkinson’s symptoms. The investment from ICIF is part of a £500,000 seed round from investors, including Amadeus Capital Partners, Crista Galli, RCA and Oxbridge Angels. The investment will be used to launch CUE 1 in the UK/EU market in early 2021. 

Pembroke VCT, the venture capital trust focused on building the brands of tomorrow, has made an initial investment of £1 million into Credentially, the platform that automates healthcare hiring, onboarding and compliance. During the pandemic, the company has worked with the NHS to speed up the registration of healthcare professionals.

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has received Clinical Trial Authorisation (CTA) from the UK Medicine and Healthcare Products Regulatory Agency (MHRA) to explore the effects of psychedelic agent psilocybin for treating short-lasting unilateral neuralgiform headache attacks (SUNHA), a rare and debilitating headache condition.

A Warwickshire-based manufacturer of fertility monitoring products, Fertility Focus, has secured further investment from MEIF through a £250,000 loan, enabling it to invest in its staff, continue research and development, while safeguarding against the impact of COVID-19.

A group of successful Bristol-based entrepreneurs has invested £192,500 into a research and development project in the city that is searching for faster diagnosis and treatment of Sepsis, which is the number one cause of death worldwide.  Sixteen members of Bristol Private Equity Club have backed GenomeKey, which is carrying out the pioneering research programme in Bristol. The investment will enable GenomeKey to leverage additional grant funding.

Birmingham-based tele-optometry manufacturer Eyoto,has secured funding from the Midlands Engine Investment Fund (MEIF) WM Equity Finance Fund, managed by venture capital firm Midven as part of a £2.5M funding round. Other investors in the round included Mercia Asset Management, the Future Fund and a group of angel investors.

Buy and build Investment group Tristone Capital, through its care division Tristone Healthcare, has acquired North Wales-based care business, ProCare (Wales) Limited.  

Liva Healthcare, a European market leader in scalable digital health coaching, has secured a new funding round of EUR 24.5 million, led by Verlinvest, the go-to investor for mission-driven entrepreneurs and category-defining global consumer brands. The investment will enable Liva to strengthen its position as a European leader in digital health and lifestyle coaching for chronic disease prevention and management.   

Peptone, the computational physics company, has built the world’s first protein engineering operating system and, thanks to $2.5 million seed round led by Hoxton Ventures and supported by dRx Capital, a venture arm of Novartis Pharma AG, Founders Factory and a number of angel investors including Brent Hoberman, the next-gen supercomputing company is now looking to further develop its groundbreaking technology in order to take on the high-value protein targets and reduce the risk of failure in early stages of drug development.